7Baggers

We provide you with 20 years of free, institutional-grade data for SILK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SILK. Explore the full financial landscape of SILK stock.

Reported DateCIKTickerType
2024-08-071397702SILK10-QUrl
2024-05-071397702SILK10-QUrl
2024-02-281397702SILK10-KUrl
2023-11-081397702SILK10-QUrl
2023-08-081397702SILK10-QUrl
2023-05-091397702SILK10-QUrl
2023-02-281397702SILK10-KUrl
2022-11-091397702SILK10-QUrl
2022-08-091397702SILK10-QUrl
2022-05-101397702SILK10-QUrl
2022-03-011397702SILK10-KUrl
2021-11-091397702SILK10-QUrl
2021-08-061397702SILK10-QUrl
2021-05-101397702SILK10-QUrl
2021-03-011397702SILK10-KUrl
2020-11-161397702SILK10-QUrl
2020-08-131397702SILK10-QUrl
2020-05-151397702SILK10-QUrl
2020-03-021397702SILK10-KUrl
2019-11-131397702SILK10-QUrl
2019-08-131397702SILK10-QUrl
2019-08-061397702SILKS-1Url
2019-05-151397702SILK10-QUrl
2019-03-041397702SILKS-1Url

Silk Road Medical, Inc
(NASDAQ:SILK) 

SILK stock logo

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly ...

Founded: 2007
IPO Price: $17 (Apr 04, 2019)
Full Time Employees: 224
CEO: Erica J. Rogers  
Sector: Healthcare
Industry: Medical Devices

Share this website to your friends
The information provided in this report about SILK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.